ATA Guidelines Tools

Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source 2015 American yroid Association Management Guidelines for Adult Patients with yroid Nodules and Differentiated yroid Cancer. DOI: 10.1089/thy.2015.0020 [remainder of citation pending publication] Available at: online.liebertpub.com/doi/ pdfplus/10.1089/thy.2015.0020 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 For additional copies, order at GuidelineCentral.com Copyright © 2015 All rights reserved ATADTCDC15122b Abbreviations 18 FDG-PET, fludeoxyglucose; AJCC, American Joint, Committee on Cancer; AST, alanine serum transferase; ATA, American yroid Association; AUS/FLUS, atypia of undetermined significance/follicular lesion of undetermined significance; CBC, complete blood count; CLIA/CAP, Clinical Laboratory Improvement Amendments/College of American Pathologists; CNS, central nervous system; CT, computed tomography; CVA, cerebrovascular accident; DTC, differentiated thyroid cancer; EBSLN, external branch of the superior laryngeal nerve; ECG, electrocardiogram; ETE, extrathyroidal extension; FDA, Food and Drug Administration; FN/SFN, follicular neoplasm/ suspicious for follicular neoplasm; FNA, fine needle aspiration; FTC, follicular thyroid cancer; FU, follow-up; GI, gastrointestinal; LN, lymph node; LT3, liothyronine; MI, myocardial infarction; MR, magnetic resonance; MRI, imaging ; MTC, medullary thyroid cancer; NED, no evidence of disease; NTCTCSG, National yroid Cancer Treatment Cooperative Study Group; PECT-CT, single-photon emission tomography/computed tomography; PEI, percutaneous ethanol injection; PTC, papillary thyroid cancer; PTEN, gene: phosphatase and tensin homolog ; RAI, radioactive iodine; RCT, randomized, controlled trial; RFA, radiofrequency ablation; rhTSH, Recombinant human thyroid- stimulating hormone; RLN, recurrent laryngeal nerve; SPM, second primary malignancy; SUSP, suspicious for papillary carcinoma; Tg, thyroglobulin; TgAb, thyroglobulin antibody; TKI, tyrosine kinase inhibitor; TSH, thyroid stimulating hormone; UICC, Union for International Cancer Control; US, ultrasound; WBS, whole body scan American yroid Association, Inc. 6066 Leesburg Pike, Suite 550 • Falls Church, Virginia 22041 Phone: 703.998.8890 • Fax: 703.998.8893 • www.thyroid.org Physician referral, patient resources available online in English and Spanish.

• Cover